Product news from the 10/24/06 News Brief
The FDA issued a non-approvable letter to Replidyne and Forest for their investigational antibiotic faropenem medoxomil.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.